Literature DB >> 16245309

MyoD recruits the cdk9/cyclin T2 complex on myogenic-genes regulatory regions.

Cristina Giacinti1, Luigi Bagella, Pier Lorenzo Puri, Antonio Giordano, Cristiano Simone.   

Abstract

During skeletal myogenesis, muscle-regulatory factors bHLH and MEF2 promote the expression of muscle-specific genes by recruiting several chromatin-modifying complexes on specific DNA regulatory sequences. A number of MyoD-interacting proteins have been reported, but whether they are recruited to the chromatin of myogenic loci, and the relationship with other chromatin bound proteins is unknown. We show that MyoD recruits cdk9/cyclin T2, together with the histone acetyltransferases p300 and PCAF, and the chromatin remodeling complex SWI/SNF, on promoters and enhancers of muscle-specific genes, and that this event correlates with the acetylation of histone tails, remodeling of chromatin, and phosphorylation of the C-terminal domain (CTD) of the RNA polymerase II at these elements. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16245309     DOI: 10.1002/jcp.20523

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

Review 1.  Regulating a master regulator: establishing tissue-specific gene expression in skeletal muscle.

Authors:  Arif Aziz; Qi-Cai Liu; F Jeffrey Dilworth
Journal:  Epigenetics       Date:  2010-11-01       Impact factor: 4.528

2.  Phosphorylation of histone H1 by P-TEFb is a necessary step in skeletal muscle differentiation.

Authors:  Siobhan K O'Brien; Kendall L Knight; Tariq M Rana
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

3.  The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2.

Authors:  Masanori Nojima; Yehong Huang; Mudit Tyagi; Hung-Ying Kao; Koh Fujinaga
Journal:  J Mol Biol       Date:  2008-07-16       Impact factor: 5.469

4.  Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.

Authors:  Yoichi Sunagawa; Tatsuya Morimoto; Tomohide Takaya; Shinji Kaichi; Hiromichi Wada; Teruhisa Kawamura; Masatoshi Fujita; Akira Shimatsu; Toru Kita; Koji Hasegawa
Journal:  J Biol Chem       Date:  2010-01-17       Impact factor: 5.157

5.  UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis.

Authors:  Shayesta Seenundun; Shravanti Rampalli; Qi-Cai Liu; Arif Aziz; Carmen Palii; SunHwa Hong; Alexandre Blais; Marjorie Brand; Kai Ge; Francis Jeffrey Dilworth
Journal:  EMBO J       Date:  2010-03-18       Impact factor: 11.598

6.  Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription.

Authors:  Qi Wang; Tara M Young; Michael B Mathews; Tsafi Pe'ery
Journal:  J Mol Biol       Date:  2007-01-12       Impact factor: 5.469

7.  The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation.

Authors:  Irene Marchesi; Francesco Paolo Fiorentino; Flavio Rizzolio; Antonio Giordano; Luigi Bagella
Journal:  Cell Cycle       Date:  2012-09-14       Impact factor: 4.534

8.  The small chromatin-binding protein p8 coordinates the association of anti-proliferative and pro-myogenic proteins at the myogenin promoter.

Authors:  Ramkumar Sambasivan; Sirisha Cheedipudi; NagaRekha Pasupuleti; Amena Saleh; Grace K Pavlath; Jyotsna Dhawan
Journal:  J Cell Sci       Date:  2009-09-01       Impact factor: 5.285

Review 9.  CDK9 keeps RNA polymerase II on track.

Authors:  Sylvain Egloff
Journal:  Cell Mol Life Sci       Date:  2021-06-19       Impact factor: 9.261

10.  The Scaffold attachment factor b1 (Safb1) regulates myogenic differentiation by facilitating the transition of myogenic gene chromatin from a repressed to an activated state.

Authors:  J Manuel Hernández-Hernández; Chandrashekara Mallappa; Brian T Nasipak; Steffi Oesterreich; Anthony N Imbalzano
Journal:  Nucleic Acids Res       Date:  2013-04-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.